Tacrolimus Capsule
Product Images NDC 0904-7097

2 FDA label images from Major Pharmaceuticals · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Tacrolimus (NDC 0904-7097). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Major Pharmaceuticals, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

244ed2fd 56b1 45fb A6aa Ebef77569880 02

244ed2fd 56b1 45fb A6aa Ebef77569880 02
Chemical structure diagram of tacrolimus monohydrate, showing the molecular framework with various functional groups and bonds represented as lines, letters, and stereochemical notations.*
FDA Label Image

Fdb1e704 Ef1d 4d9e A173 Ffe17c093790 00

Fdb1e704 Ef1d 4d9e A173 Ffe17c093790 00
The packaging label for Tacrolimus capsules, USP 1 mg, from Major Pharmaceuticals shows it as an oral human prescription drug. It includes the strength (1 mg), the unit dose format, a quantity of 100 capsules, and instructions to dispense with patient information leaflets. Storage instructions and manufacturer details (Strides Pharma Science Ltd and Major Pharmaceuticals) are also visible along with the NDC number 0904-7097-61.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.